Show simple item record

dc.contributor.authorPalma-Álvarez, Raul Felipe
dc.contributor.authorDaigre, Constanza
dc.contributor.authorRos-Cucurull, Elena
dc.contributor.authorPerea-Ortueta, Marta
dc.contributor.authorOrtega-Hernández, Germán
dc.contributor.authorRíos-Landeo, Ana
dc.contributor.authorRoncero Alonso, Carlos 
dc.contributor.authorRamos-Quiroga, Josep Antoni
dc.contributor.authorGrau-López, Lara
dc.date.accessioned2025-01-29T14:58:10Z
dc.date.available2025-01-29T14:58:10Z
dc.date.issued2023
dc.identifier.citationPalma-Alvarez, R. F., Daigre, C., Ros-Cucurull, E., Perea-Ortueta, M., Ortega-Hernández, G., Ríos-Landeo, A., ... & Grau-López, L. (2023). Clinical features and factors related to lifetime suicidal ideation and suicide attempts in patients who have had substance-induced psychosis across their lifetime. Psychiatry research, 323, 115147.es_ES
dc.identifier.issn0165-1781
dc.identifier.urihttp://hdl.handle.net/10366/163112
dc.description.abstract[EN]Suicidal behaviors are common among patients with substance use disorders (SUD). However, the prevalence and clinical factors related to suicide behaviors among patients who have had substance-induced psychosis (SIP) is unknown. This study aims to explore the prevalence, clinical features, and factors related to lifetime suicidal ideation (SI) and suicide attempts (SA) in patients who have had SIP across their lifetime. A cross-sectional study was conducted in an outpatient center for addiction treatment between 01/01/2010 and 12/31/2021. 601 patients were evaluated with validated scales and questionnaires (79.03% males; M age 38.11±10.11 years). The prevalence of SI and SA was 55.4% and 33.6%, respectively. SI was independently related to any type of lifetime abuse, depressive spectrum disorders, benzodiazepine use disorder, borderline personality disorder, and the level of depressive symptoms. SA was independently associated with lifetime physical abuse, benzodiazepine use disorder, the number of psychotic symptoms, borderline personality disorder, and the level of depressive symptoms. The main factors related to SI and SA in those patients should be evaluated in daily clinical practice and considered in any approach to clinical practice as well as in health policies targeting suicide prevention.es_ES
dc.language.isoenges_ES
dc.subjectPsychosises_ES
dc.subjectSuicidees_ES
dc.subjectDrug dependencees_ES
dc.subject.meshSuicide *
dc.subject.meshDrug-Seeking Behavior *
dc.titleClinical features and factors related to lifetime suicidal ideation and suicide attempts in patients who have had substance-induced psychosis across their lifetimees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1016/j.psychres.2023.115147es_ES
dc.subject.unesco3211 Psiquiatríaes_ES
dc.subject.unesco6113.04 Efecto de las Drogases_ES
dc.identifier.doi10.1016/j.psychres.2023.115147
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.journal.titlePsychiatry Researches_ES
dc.volume.number323es_ES
dc.page.initial115147es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsconducta del consumo de drogas *
dc.subject.decssuicidio *


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record